Jointown Pharmaceutical Group (600998.SH): The Drug Registration Certificate for Promethazine Hydrochloride Injection is obtained.

16:16 26/12/2025

Kyushu Tong (600998.SH) announced that on December 25, 2025, its subsidiary Beijing Jingfeng Pharmaceutical Group Co. Ltd. (referred to as "Jingfeng Pharmaceutical") received the Drug Registration Certificate for the injection of promethazine hydrochloride approved and issued by the National Medical Products Administration for its subsidiary Huiyu Yuanhe (Hainan) Pharmaceutical Co., Ltd. (referred to as "Huiyu Yuanhe").

Jointown Pharmaceutical Group (600998.SH) announced that on December 25, 2025, its subsidiary Beijing Jingfeng Pharmaceutical Group Co., Ltd. (referred to as "Jingfeng Pharmaceutical") subsidiary, Huiyu Yuanhe (Hainan) Pharmaceutical Co., Ltd. (referred to as "Huiyu Yuanhe"), has received the drug registration certificate issued by the National Medical Products Administration for the hydrochloride metoclopramide injection. Hydrochloride metoclopramide injection is an anti-histamine drug used for allergic reactions of the skin and mucosa, motion sickness, as an adjunct treatment for anesthesia and before and after surgery, and for the prevention and treatment of radiation-induced or drug-induced nausea and vomiting.

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.